According to FutureWise analysis the market for fibrin sealant in 2023 was US$ 1.32 billion, and is expected to reach US$ 2.78 billion by 2031 at a CAGR of 9.72%. Fibrin sealant is a groundbreaking biological agent that plays a vital role in controlling bleeding during surgeries and in cases of traumatic injuries, especially when traditional methods like suturing, ligation, or cautery...